(Press-News.org) Diabetes, a metabolic disease, is on the rise worldwide, and over 90 percent of cases are type 2 diabetes, where the body does not effectively respond to insulin. Researchers from Mass General Brigham and Albert Einstein College of Medicine identified metabolites (small molecules found in blood generated through metabolism) associated with risk of developing type 2 diabetes in the future and revealed genetic and lifestyle factors that may influence these metabolites. They also developed a metabolomic signature that predicts future risk of type 2 diabetes beyond traditional risk factors. Their results are published in Nature Medicine.
In this study, researchers tracked 23,634 individuals with diverse ethnic backgrounds across 10 prospective cohorts with up to 26 years of follow-up. These individuals were initially free of type 2 diabetes. The team analyzed 469 metabolites in blood samples, as well as genetic, diet, and lifestyle data, to see how they relate to risk of developing type 2 diabetes. Of the metabolites examined, 235 were found to be associated with a higher or lower risk of developing type 2 diabetes, 67 of which were new discoveries.
“Interestingly, we found that diet and lifestyle factors may have a stronger influence on metabolites linked to type 2 diabetes than on metabolites not associated with the disease,” said first and co-corresponding author Jun Li, MD, PhD, an assistant professor of Medicine and associate epidemiologist in the Mass General Brigham Department of Medicine. Li is also an assistant professor in the Department of Nutrition at Harvard T.H. Chan School of Public Health. “This is especially true for obesity, physical activity, and intake of certain foods and beverages such as red meat, vegetables, sugary drinks, and coffee or tea. Increasing evidence suggests that these dietary and lifestyle factors are associated with greater or lower risk of type 2 diabetes. Our study revealed that specific metabolites may act as potential mediators, linking these factors with type 2 diabetes risk.”
The metabolites associated with type 2 diabetes were also found to be genetically linked to clinical traits and tissue types that are relevant to the disease. Furthermore, the team developed a unique signature of 44 metabolites that improved prediction of future risk of type 2 diabetes.
“Our study is the largest and most comprehensive investigation of blood metabolic profiles associated with the risk of type 2 diabetes that integrates genomic and diet and lifestyle data from a wide range of people, and lays important groundwork for future studies,” said senior and co-corresponding author Qibin Qi, PhD, professor in the Department of Epidemiology & Population Health and associate director of that department's Center for Population Cohorts at Albert Einstein College of Medicine.
“While these new findings offer important insights, additional experimental studies and clinical trials are needed to confirm the causality of these associations and clarify how these metabolic pathways contribute to the development of type 2 diabetes.”
The collaborative research team plans to continue investigating why people develop diabetes through different biological pathways, with the goal of helping develop more targeted prevention strategies for individuals at high risk.
“A better understanding of the biological pathways behind disease can help drive the development of new treatments,” said Li. “Our findings lay the groundwork for a deeper understanding of type 2 diabetes and may help inform the development of precision preventive strategies targeting specific metabolic pathways.”
Authorship: In addition to Li, Mass General Brigham authors include Jie Hu, Zhendong Mei, Shilpa N. Bhupathiraju, A. Heather Eliassen, JoAnn E. Manson, Jose C. Florez, Miguel Angel Martínez-González, Kathryn M. Rexrode, James B. Meigs, and Frank B. Hu. In addition to Qi, Einstein authors include Kai Luo, Chengyong Jia, and Robert C. Kaplan. Additional authors include Huan Yun, Xingyan Wang, Marta Guasch-Ferré, Xikun Han, Buu Truong, Jordi Merino, Miguel Ruiz-Canela, Casey M. Rebholz, Eun Hye Moon, Taryn Alkis, Guning Liu, Jie Yao, Xiyuan Zhang, Bianca C. Porneala, Jordi Salas-Salvadó, Thomas J. Wang, Josée Dupuis, Elizabeth Selvin, Xiuqing Guo, Jennifer A. Brody, Yongmei Liu, Alexis C. Wood, Kari E. North, Su Yon Jung, Ching-Ti Liu, Nona Sotoodehnia, Simin Liu, Lesley F. Tinker, Robert E. Gerszten, Clary B. Clish, Liming Liang, Rozenn N. Lemaitre, Katherine L. Tucker, Stephen S. Rich, Jerome I. Rotter, Eric Boerwinkle, and Bing Yu.
Disclosures: Rich is a consultant to Westat, the Administrative Coordinating Center for the NHLBI Trans-Omics for Precision Medicine (TOPMed) program. The remaining authors declare no competing interests.
Funding: The current study is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) including R01DK119268 and R00DK122128. Other funding sources for this study include R01HL060712, R01HL170904, R01HL136266, and HHSN268201600034I (contract to the Broad Institute) from the National Heart, Lung and Blood Institute (NHLBI); R01DK126698, R01DK081572, U01DK140761, R01DK134672, R01DK120870, and the New York Regional Center for Diabetes Translation Research (P30DK111022) from NIDDK; R01AG085320 from National Institute on Aging; and a cooperative agreement UM1HG008898 from the National Human Genome Research Institute (NHGRI).
Paper cited: Li J et al. “Circulating metabolites, genetics, and lifestyle factors in relation to future risk of Type 2 diabetes” Nature Medicine DOI: 10.1038/s41591-025-04105-8
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. Einstein is home to nearly 1,000 M.D., Ph.D., M.D./Ph.D. students, more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates, and six NIH-funded research centers in cancer, intellectual development disorders, clinical and translational research, AIDS, and two in diabetes. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. For more information, please visit einsteinmed.edu, follow us on Twitter, Facebook, Instagram, LinkedIn, and view us on YouTube.
END
New study identifies signature in blood to better predict type 2 diabetes risk
2026-01-14
ELSE PRESS RELEASES FROM THIS DATE:
Research spotlight: developing “smart” nanoparticles to deliver targeted gene therapy in osteoarthritis
2026-01-14
Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior authors of a paper published in Nature Nanotechnology, “A disease-severity-responsive nanoparticle enables potent ghrelin mRNA therapy in osteoarthritis.” Mahima Dewani, PhD, is the lead author of this study.
Q: How would you summarize your study for a lay audience?
Osteoarthritis is a highly prevalent joint disease that leads to cartilage breakdown, pain and disability, yet there are still no FDA-approved treatments that can slow or reverse its progression. RNA-based ...
A CRISPR fingerprint of pathogenic C. auris fungi
2026-01-14
(BOSTON) — Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by other illnesses. The pathogen easily spreads and colonizes surfaces and objects where it can survive for weeks to months, and is often resistant to standard disinfectants. C. auris infections are especially problematic for patients who receive organ transplants or chemotherapy, and whose immune systems are compromised, ...
Time warp: How marketers express time can affect what consumers buy
2026-01-14
Which feels further back in time: the year 2016, or 10 years ago? And which feels closer: 2036, or 10 years from now?
According to new research from the UBC Sauder School of Business, the way time is expressed—as a calendar year or as a length of time—can change how people experience the past and the future, and influence real consumer decisions.
That matters because time-based language is everywhere and could affect how much people are willing to pay. For example, which whiskey would consumers be willing to pay more ...
CBD treatment reverses key effects of fetal alcohol spectrum disorder in a mouse model
2026-01-14
Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal alcohol spectrum disorder (FASD), a condition caused by alcohol exposure during pregnancy. This is one of the main conclusions of a preclinical study conducted in mice by researchers at the Institute for Neurosciences (UMH–CSIC).
Published in Biomedicine & Pharmacotherapy, the study shows that CBD treatment normalizes emotional behavior and vulnerability to addiction in animals exposed to alcohol ...
Blood sugar spikes linked to higher risk of Alzheimer's disease
2026-01-14
A new study led by researchers from the University of Liverpool has found that spikes in blood sugar after meals may increase the risk of Alzheimer's disease.
Whilst research has long suggested that hyperglycaemia, diagnosed type 2 diabetes mellitus and insulin resistance strongly relate to worse brain health, specifically increasing the risk of cognitive decline and dementias, the underlying mechanisms are poorly understood.
Using data from the UK Biobank, the team analysed genetic data from over 350000 individuals aged between 40 and 69 years of age. They focused on markers of how ...
Staying single for longer affects young people’s well-being
2026-01-14
Media increasingly portray being single as an expression of people’s lifestyle, self-determination and empowerment, with expressions such as self-partnership, solo living, sologamy and singlehood dominating the discourse. At the same time, more and more young adults are opting not to engage in a committed romantic relationship. A research team led by the University of Zurich (UZH) has now investigated how being single long-term affects people’s well-being. The researchers drew on data from more than 17,000 young people in Germany and the United Kingdom who had no prior relationship experience at the start of the study. Participants were surveyed annually from the ages of ...
New method allows scientists to 3D-print structures within cells
2026-01-14
Researchers have developed a way to 3D print custom micrometer-sized structures directly into the interior of living cells. As reported in Advanced Materials, the investigators used their method to print complex microstructures in shapes including barcodes, geometric patterns, and even a tiny elephant.
The breakthrough involves injecting a cell with a bio-compatible light-sensitive material called photoresist and then treating the cell with a special laser that polymerizes the photoresist into an intracellular structure with submicron resolution. A cell treated with this method not only contains the newly ...
Screening tool helps identify brain-related comorbidities in individuals with Duchenne muscular dystrophy
2026-01-14
In research published in Developmental Medicine & Child Neurology, investigators developed a brief, reliable, and valid screening tool to help identify individuals with Duchenne muscular dystrophy (a neuromuscular disorder) who are at increased risk of brain-related comorbidities, such as language disorders, attention-deficit/hyperactivity disorder, and anxiety.
The research team developed the questionnaire-based screening tool, called the BIND (Brain Involvement iN Dystrophinopathies) screener, by reviewing the medical literature and incorporating expert consensus, ...
How do the active ingredients of monkfruit affect health?
2026-01-14
Luohan Guo (Siraitia grosvenorii), or monkfruit, is a perennial vine in the gourd family that has substantial antioxidant levels and is native to China. New research published in the Journal of the Science of Food and Agriculture provides insights into the active compounds of Luohan Guo and their health-promoting properties.
A key characteristic of Luohan Guo is its richness in secondary metabolites, particularly terpenoids, flavonoids, and amino acids. Investigators identified these within the peels and pulps of four Luohan Guo varieties and determined how these metabolites interact with antioxidant receptors and other targets involved in various pathways that ...
News language and social networks: how do they affect the spread of immigration attitudes?
2026-01-14
A study in Economic Inquiry reveals how changes in immigration attitudes in an area spread to other localities and highlights the role of media language and social networks in shaping political attitudes.
The work draws on the Associates Press’ switch in 2013 from recommending the term “illegal immigrant” to outright banning it. The Associated Press is a collaboration of thousands of newspapers, and the ban was not politically motivated but instead came as part of a broader language policy change that prohibited labeling people.
Different newspapers across the United States rely on Associated Press material to varying degrees, and researchers found that people ...